Skip to content

Lucid Diagnostics LUCD Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Guardant Health logo
Guardant HealthGH
$201.09M+5.8%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$25.12M-1.8%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
$1.97M-18.2%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$7.94M+52.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$37.9M-8.9%
Danaher logo
DanaherDHR
$1.2B+9.1%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's operating lease liabilities (total)?
Lucid Diagnostics (LUCD) reported operating lease liabilities (total) of $1.6M in Q1 2026.
How has Lucid Diagnostics's operating lease liabilities (total) changed year-over-year?
Lucid Diagnostics's operating lease liabilities (total) decreased by 35.1% year-over-year, from $2.47M to $1.6M.
What is the long-term trend for Lucid Diagnostics's operating lease liabilities (total)?
Over 3 years (2022 to 2025), Lucid Diagnostics's operating lease liabilities (total) has grown at a -3.1% compound annual growth rate (CAGR), from $2M to $1.82M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.